Advertisement

Role of Epstein-Barr Virus in Acquired Immune Deficiency Syndrome

  • David T. Purtilo
  • Helen Kipscomb
  • Gerhard Krueger
  • Joseph Sonnabend
  • Dominic Casareale
  • David J. Volsky
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 187)

Abstract

Human lymphotropic viruses including human T cell leukemia virus-III (HTLV-III), Epstein-Barr virus (EBV), and cytomegalovirus (CMV) likely serve important etiological roles in the induction of the acquired immune deficiency syndrome (AIDS) and in the AIDS-related malignancies. By infecting the cellular components of the immune system, these viruses alter the balance between the various lymphocyte subpopulations and affect immune regulation as well.1–3 HTLV-III is thought to be important in the induction of AIDS, especially for the final stages in the pathogenesis, owing to infection and lysis of T helper cells. CMV and EBV have been implicated in the induction of both benign and malignant disorders in patients with AIDS, including Kaposi’s sarcoma and malignant B cell lymphoma, respectively.4

Keywords

Acquire Immune Deficiency Syndrome Infectious Mononucleosis Immune Deficiency Syndrome Male Homosexual Acquire Immune Deficiency Syndrome Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    F. Barre-Sinoussi, J.-C. Chermann, F. Rey, T. Nugeyre, S., Chamaret, J. Gruest, C. Dauguet, and C. Axler-Blin, Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220: 868 (1983).PubMedCrossRefGoogle Scholar
  2. 2.
    P. Pattengale, R.W. Smith, and P. Gerber, Selective transformation of B lymphocytes by E.B. virus. Lancet 2: 93 (1973).PubMedCrossRefGoogle Scholar
  3. 3.
    G.P.A. Rice, R.D. Schrier, and M.B.A. Oldstone, Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products. Proc. Natl. Acad. Sei. USA 81: 6134 (1984).CrossRefGoogle Scholar
  4. 4.
    D.T. Purtilo, H. Lipscomb, S. Harada, J. Hayes, G. Manolov, Y. Manolova, S. Witkin, and J. Sonnabend, Etiological factors in the induction of acquired immune deficiency syndrome (AIDS), in: “Clinical Laboratory Molecular Analyses: New Strategies in Autoimmunity, Cancer and Virology,” R. Nakamura, ed., Grune and Stratton, New York (in press).Google Scholar
  5. 5.
    W. Henle, G. Henle, and E.T. Lennette, The Epstein-Barr virus, Sei. An. 241: 48 (1979).Google Scholar
  6. 6.
    J.W. Sixbey, J.G. Nedrud, N. Raab-Traub, R.A. Hanes, and J.S. Pagano, Epstein-Barr virus replication in oropharyneal epithelial cells, N. Engl. J. Med. 310: 1225 (1984).PubMedCrossRefGoogle Scholar
  7. 7.
    H. Wolf, 17 Wilnes, and S.G.J. Bayliss, Epstein-Barr virus: its site of persistence and its role in the development of carcinomas, in: “Modern Trends in Human Leukemia, IV,” Neth, Springer-Verlag, Heideiburg, Berlin (1981).Google Scholar
  8. 8.
    D.T. Purtilo, “Immune Deficiency and Cancer: Epstein-Barr Virus and Lymphoproliferative Malignancies,” Plenum Press, New York (1984).Google Scholar
  9. 9.
    D.T. Purtilo, Immune deficiency predisposing to Epstein-Barr virus-induced lymphoproliferative diseases: the X-linked lymphoproli¬ferative syndrome as a model, Adv. Cancer Res. 34: 279 (1980).CrossRefGoogle Scholar
  10. 10.
    D.T. Purtilo, Hypothesis: pathogenesis and phenotypes of an X-linked recessive lymphoproliferative syndrome, Lancet 2: 882 (1976).PubMedCrossRefGoogle Scholar
  11. 11.
    G. Tosato, I. Magrath, I. Koski, N. Dooley, and M. Blaese, Activation of suppressor T cells during Epstein-Barr-virus-induced infectious mononucleosis, N. Engl. J. Med. 301: 1133 (1979).PubMedCrossRefGoogle Scholar
  12. 12.
    J. Robinson, D. Smith, and J. Niederman, Plasmacytic differentiation of circulating Epstein-Barr virus-infected B lymphocytes during acute infectious mononucleosis, J. exp. Med. 153: 235 (1981).PubMedCrossRefGoogle Scholar
  13. 13.
    A. Rosen, P. Gergely, M. Jondal, G. Klein, and S. Britton, Polyclonal Ig production after Epstein-Barr virus infection in human lymphocytes in vitro, Nature 267: 52 (1977).PubMedCrossRefGoogle Scholar
  14. 14.
    R.T. Schooley, P. Densen, D. Harmon, D. Velzenstein, M.S. Hirsch, W. Henle, and S. Whitzman, Anti-neutrophil antibodies in infectious mono-nucleosis, Am. J. Med. 76: 85 (1984).Google Scholar
  15. 15.
    J. Linder and D.T7~Purtilo, Infectious mononucleosis, jm: “Immune Deficiency and Cancer: Epstein-Barr Virus and Lymphoproliferative Malignancies,” D.T. Purtilo, ed., Plenum Press, New York, p. 11 (1984).Google Scholar
  16. 16.
    D.T. Purtilo, Immunopathology of X-linked lymphoproliferative syndrome, Immunol. Today 4: 291 (1983).CrossRefGoogle Scholar
  17. 17.
    O.T. Purtilo, K. Sakamoto, V. Barnabei, J. Seeley, T. Bechtold, G. Rogers, J. Yetz, and S. Harada, Epstein-Barr virus-induced diseases in males with the X-linked lymphoproliferative syndrome (XLP), Am. J. Med. 73: 49 (1982).PubMedCrossRefGoogle Scholar
  18. 18.
    D. Weisenburger and D.T. Purtilo, Failures in immunological control of EB virus infection: fatal infectious mononucleosis, in, “The Epstein-Barr Virus: Recent Advances,” M.A. Epstein and ETG. Achong, William Heinemann Medical Books, Ltd., England, in pressGoogle Scholar
  19. 19.
    S. Harada, T. Bechtold, and D.T. Purtilo, Cel1-mediated immunity to Epstein-Barr virus (EBV) and natural killer (NK)-cell activity in X-linked lymphoproliterative syndrome, Int. J. Cancer 216: 739 (1982).Google Scholar
  20. 20.
    S. Argov, D. Johnson, M. Collins, H.S. Koren, H. Lipscomb, and D.T. Purtilo, Loss of natural killing (NK) activity but retention of lymphocyte mediated antibody-dependent cellular cytotoxicity (ADCC) in patients with the X-linked lymphoproliferative syndrome (XLP), submitted for publication.Google Scholar
  21. 21.
    A. Rubinstein,M. Sicklick, A. Gupta, L. Bernstein, N. Klein, E. Rubinstein, I. Spigland, L. Fruchter, N. Litman, H. Lee, and M. Hollander, Acquired immunodeficiency with reversed T4/T8 ratios in infants born to promiscuous and drug-addicted mothers, J. Am. Med. Assoc. 249: 2325 (1983).Google Scholar
  22. 22.
    J. Oleske, A. RTnnefor, R. Cooper, K. Thomas, A. dela Cruz, H. Ahdieh, I. Guerrero, V.V. Joski, and F. Desposito, Immune deficiency syndrome in children, J. Am. Med. Assoc. 249: 2345 (1983).CrossRefGoogle Scholar
  23. 23.
    R.J. McDonough, J.J. Madcien, A.TaTek, D.A. Shafer, M. Pline, D. Gordon, P. Bokos, J.C. Kuehnle, and J. Mendelson, Ateration of T and null lymphocyte frequencies in the peripheral blood of human opiate receptor sites on T lymphocytes, J. Immunol. 125: 2539 (1980).PubMedGoogle Scholar
  24. 24.
    F. Gervais, C. Tsoukas, A. Fuks, and J. Shuster, Natural history of the AIDS related complex in hemophilia - relationships to Epstein- Barr virus, AIDS Res. 1: 1 97 (1984).Google Scholar
  25. 25.
    Mobidity and Mortality Weekly Report, Update: acquired immunodeficiency syndrome (AIDS) - United States, 32: 688 (1984).Google Scholar
  26. 26.
    Morbidity and Mortality Weekly Report, Opportunistic infections and Kaposi’s sarcoma among Haitians in the United States 31: 353 (1982).Google Scholar
  27. 27.
    A.E. Pitchenik, M.A. Fischl, G.M. Dickinson, D.M. Becker, A.M. Fournier, M.T. O’Connell, R.M. Colton, and T.J. Spira, Opportunistic infections and Kaposi’s sarcoma among Haitians: evidence of a new acquired immunodeficiency state. Ann. Intern. Med. 98: 277 (1983).PubMedGoogle Scholar
  28. 28.
    R.B. Purtilo, J. Sonnabend, and D.T. Purtilo, Confidentiality, informed consent and untoward social consequences in research on a “new killer disease” (AIDS), Clin. Res. 31: 462 (1983).Google Scholar
  29. 29.
    D.T. Purtilo and D.H. Connor, Fatal infections in protein-calorie malnourished children with thymolymphatic atrophy, Arch. Pis. Childh. 50: 1 49 (1975).Google Scholar
  30. 30.
    J. Sonnabend, S. Witkin, and D.T. Purtilo, Acquired immunodeficiency syndrome, opportunistic infections, and malignancies in male homo¬sexuals. A hypothesis of etiologic factors in pathogenesis, J. Am. Med. Assoc. 249:2370 (1983). —Google Scholar
  31. 31.
    G.R.F. Krueger, W. Otten, M. Ortmann, L. Haussermann, C. Rasokat, K. Degenhardt, R. Hehlmann, H. Wolf, W. Auffermann, A. Bocking, and A. Ramon, Immunopathology of AIDS (acquired immune deficiency syndrome). Observations in 54 patients with pre-AIDS and AIDS. Path. Res. Pract. (in press) (1984).Google Scholar
  32. 32.
    H. Lipscomb, E. Tatsumi, S. Harada, J. Sonnabend, J. Wallace, J. Yetz, J. Davis, K. McClain, C. Metroka, R. Tubbs, and D.T. Purtilo, Epstein-Barr virus, chronic lymphadenomegaly, and lymphoma in male homosexuals with acquired immunodeficiency syndrome (AIDS). AIDS Res. 1:59 (1 983).Google Scholar
  33. 33.
    M. Marmor, L. Laubenstein, D.C. William et al., Risk factors for Kaposi’s sarcoma in homosexual men, Lancet 2: 125 (1982).Google Scholar
  34. 34.
    R. DuBois, J. Seeíey, S. Harada, M. Bal low, and D.T. Purtilo, Chronic Epstein-Barr virus infection and mononucleosis, Southern Med. J. 77: 1376 (1984).Google Scholar
  35. 35.
    D.TTT Crawford, I. Willard, I. Leiscu, and D.W. Wara, Epstein-Barr (EB) virus infection in homosexual men in London, Br. j. Vener. Pis. 60: 258 (1984).Google Scholar
  36. 36.
    J.L. Ziegler, J.A. Beckstead, P.A. Volberding, D.I. Abrams, A. M. Levine, R.J. Lukes, P.S. Gill, R.L. Burkes, P.R. Meyer, C.E. Metroka, J. Mouradian, A. Morre, S.A. Riggs, J.J Butler, F.C. Cabañil las, E. Hersh, G.R. newell, L.J. Laubenstein, D. Knowles, C* Odajnyk, B. Raphael, B. Koziner, C. Urmacher, and B. D. Clarkson, Non-Hodgkin’s lymphoma in 90 homosexual men. Relation to generalized lymphadenopathy and the acquired immuno¬deficiency syndrome, N. Engl. J. Med. 311: 565 (1984).PubMedCrossRefGoogle Scholar
  37. 37.
    J.L. Ziegler, R.C. Miner, E. Roseríbaum, E.T. Lennette, E. Shillitoe, C. Casavant, W.L. Drew, L. Mintz, J. Gershow, J. Greenspan, J. Beckstead, and K. Yamamoto, Outbreak of Burkitt’s-like lymphoma in homosexual men, Lancet 2: 631 (1982).PubMedCrossRefGoogle Scholar
  38. 38.
    J.M. Petersen, R.R. Tubbs, R.A. Savage, L.C. Calabrese, M.R. Proffitt, Y. Manolova, G. Manolov, A. Schumaker, E. Tatsumi, K. McClain, and D.T. Purtilo, Small noncleaved B cell Burkitt-type lymphoma with chromosome t(8;14) translocation and carrying Epstein-Barr virus in a male homosexual with the acquired immune deficiency syndrome, Am. J. Med., in press (1984).Google Scholar
  39. 39.
    R.S.K. Chaganti, C. Suresh, B.K. Jhanwar, Z. Arlin, R. Mertelsmann, and B.D. Clarkson, Specific translocations characterize Burkitt’s like lymphoma of homosexual men with the acquired immunodeficiency syndrome, Blood 61: 1 265 (1983).Google Scholar
  40. 40.
    I. Magrath, J. Erikson, J. Whang-Peng, H. Sieverts, G. Armstrong, D. Benjamin, T. Triche, O. Alabaster, and C.M. Croce, Synthesis of kappa light chains by cell lines containing an 8;22 chromosom¬al translocation derived from a male homosexual with Burkitt’s lymphoma, Science 222: 1094 (1983).PubMedCrossRefGoogle Scholar
  41. 41.
    P. Leder, J. Battey, G. Lenoir, C. Moulding, W. Murphy, H. Potter, T. Steward, and R. Taub, Translocations among antibody genes in human cancer, Science 222: 765 (1983).PubMedCrossRefGoogle Scholar
  42. 42.
    W. Auffermann, G.R.F. Krueger, and A. Bocking, Chromatinverteilung und DNS-Gehalt bei AIDS als Zeichen viraler Infektion-Analyse durch DNA Bildzytometrie, Verh. Dtsch. Ges. Path, 68: (in press) (1984).Google Scholar
  43. 43.
    G. Manolov, Y. Manolova, J. Sonnabend, H. Lipscomb, and D.T. Purtilo, Chromosome aberrations in peripheral lymphocytes of pro¬miscuous male homosexuals predisposed to acquired immune deficiency syndrome (AIDS), AIDS Res. 1: 157 (1984).CrossRefGoogle Scholar
  44. 44.
    A.S. Fauci, The acquired immune deficiency syndrome, J. Ato. Med. Assoc. 249: 2375 (1983).CrossRefGoogle Scholar
  45. 45.
    L. Hutt-Fletcher, N. Balchandarn, and M.H. Elkins, B cell activation by cytomegalovirus, J. Exp. Med. 1 58:21 71 (1 983).Google Scholar
  46. 46.
    H.C. Lane, H. Masur, LTTT. T5gar, G. Whalen, A.H. Rook, and A.S. Fauci, Abnormalities of B cell activation and immunoregulation in patients with the acquired immune deficiency syndrome, N. Engl J. Med. 309: 453 (1983).Google Scholar
  47. 47.
    C. Garzeiii, F.E. Taub, J.E. Scharff, B.S. Prabhakar, F. Ginsberg- Gel Iner, and A.L. Notkins, Epstein-Barr virus-transformed lympho¬cytes produce monoclonal autoantibodies that react with antigens in multiple organs, j. Virol. 52: 722 (1984).Google Scholar
  48. 48.
    L. Montagnier, J. Gruest, S. Chamaret, C. Dauguet, C. Axler, D. Guetard, M.T. Nugeyre, F. Barre-Sinoussi, J.-C. Chermann, D. Klatzmann, and J.C. Gluckman, Adaptation of lymphadenopathy-associated virus (LAV) to replication in EBV-transformed B lymphoblastoid cell lines, Science 225: 63 (1984).PubMedCrossRefGoogle Scholar
  49. 49.
    D. Casareale, and D.J. Volsky, Isolation of EBV- and HTLV-III- carrying B cell lines from blood of patients with lymphoadeno- pathy and AIDS, submitted for publication.Google Scholar
  50. 50.
    R.S. Schwartz, Immunoregulation, oncogenic viruses, and malignant lymphomas, Lancet 2: 1266 (1972).CrossRefGoogle Scholar
  51. 51.
    D. Casareale, J. Sonnabend, F. Sinangil, D.T. Purtilo, and D.J. Volsky, Detection of retroviruses in blood of patients with acquired immune deficiency syndrome (AIDS)-related conditions and in healthy individuals from New York City, submitted for publication.Google Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • David T. Purtilo
    • 1
    • 2
    • 3
  • Helen Kipscomb
    • 1
    • 3
  • Gerhard Krueger
    • 4
  • Joseph Sonnabend
    • 5
  • Dominic Casareale
    • 1
  • David J. Volsky
    • 1
    • 3
  1. 1.Department of Pathology and Laboratory MedicineThe University of Nebraska Medical CenterUSA
  2. 2.PediatricsThe University of Nebraska Medical CenterUSA
  3. 3.The Eppley Institute for Research in Cancer and Allied DiseasesOmahaUSA
  4. 4.Immunopathology Laboratories, Pathology InstituteUniversity of Cologne, Clinical Center LindenburgWest Germany
  5. 5.New YorkUSA

Personalised recommendations